Kang, Huining
Sharma, Nitesh D.
Nickl, Christian K.
Devidas, Meenakshi
Loh, Mignon L.
Hunger, Stephen P.
Dunsmore, Kimberly P.
Winter, Stuart S.
Matlawska-Wasowska, Ksenia https://orcid.org/0000-0002-9903-5793
Funding for this research was provided by:
National Institutes of Health (8UL1TR000041, U10 CA98543, U10 CA98413, U24 CA114766, U10 CA180886, U10 CA180899)
National Cancer Institute (P30CA118100)
Gabrielle’s Angel Foundation for Cancer Research
Dedicated Health Research Funds from the University Of New Mexico School Of Medicine
Article History
Received: 21 May 2018
Accepted: 29 July 2018
First Online: 23 August 2018
Ethics approval and consent to participate
: All patients or their parent(s)/guardian(s) provided written, informed consent for future research in accordance with the Declaration of Helsinki and local institutional guidelines. The study was approved by the Human Research Review Committee at the University of New Mexico Health Sciences Center (IRB #03-183).
: Not applicable.
: Hunger: <i>Merck:</i> Equity Ownership; <i>Sigma Tau:</i> Consultancy; <i>Jazz Pharmaceuticals:</i> Consultancy; <i>Spectrum Pharmaceuticals:</i> Consultancy. The remaining authors have no conflicts to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.